$High Efficacy of the PARP Inhibitor Olaparib Combined with High-Dose Chemotherapy and Autologous Stem-Cell Transplant for Refractory Lymphomas$

High Efficacy of the PARP Inhibitor Olaparib Combined with High-Dose Chemotherapy and Autologous Stem-Cell Transplant for Refractory Lymphomas

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2022-11, Vol.140 (Supplement 1), p.1183-1184
Hauptverfasser:	Nieto, Yago, Valdez, Benigno C, Thall, Peter F, Ramdial, Jeremy L., Srour, Samer A, Hosing, Chitra, Saini, Neeraj, Alousi, Amin M, Qazilbash, Muzaffar H, Popat, Uday R, Gulbis, Alison, Shigle, Terri Lynn, Bassett, Roland, Guillermo-Pacheco, Maria, Ledesma, Celina, Strati, Paolo, Ahmed, Sairah, Steiner, Raphael, Westin, Jason, Nair, Ranjit, Iyer, Swaminathan P., Champlin, Richard E, Shpall, Elizabeth J, Andersson, Borje S
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!